E
Ephla Bio focuses on developing targeted B-cell therapeutics for various medical conditions. The company leverages advanced biological research to engineer precise treatments aimed at specific immune cell populations. This focus allows for the creation of novel therapies designed to modulate immune responses effectively.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Ephla Bio focuses on developing targeted B-cell therapeutics for various medical conditions. The company leverages advanced biological research to engineer precise treatments aimed at specific B-cell populations. This approach seeks to offer effective therapeutic options by modulating immune responses through targeted intervention.